GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Total Equity

Toleranzia AB (OSTO:TOL) Total Equity : kr152.73 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB Total Equity?

Toleranzia AB's total equity for the quarter that ended in Mar. 2024 was kr152.73 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Toleranzia AB Total Equity Historical Data

The historical data trend for Toleranzia AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Toleranzia AB Total Equity Chart

Toleranzia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.99 67.92 127.96 119.51 153.52

Toleranzia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.56 115.06 155.54 153.52 152.73

Toleranzia AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Toleranzia AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=160.427-6.909
=153.52

Toleranzia AB's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=156.6-3.867
=152.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Toleranzia AB Total Equity Related Terms

Thank you for viewing the detailed overview of Toleranzia AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Toleranzia AB (OSTO:TOL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Total Equity
Comparable Companies
XSAT:DANCAN OSTO:NANEXA OSTO:MOB OSTO:ERMA OSTO:ALZCUR XSAT:PMED OSTO:NEWBRY XSAT:ODI OSTO:GABA XSAT:ACUC XTER:MRK ZTS TSE:4502 NSE:SUNPHARMA CTLT TSE:4507 SHSE:600196 SZSE:000538 VTRS NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
Erik Dahlbergsgatan 11A, Gothenburg, SWE, SE-411 26
Website
https://www.toleranzia.com
Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.